Why the study?
Oxidative stress contributes to cisplatin-induced cardiotoxicity, prompting investigation into the protective effects of the antioxidant N-acetylcysteine.
Does N-acetylcysteine reduce cisplatin-induced cardiotoxicity in a rat model?
Does N-acetylcysteine reduce cisplatin-induced cardiotoxicity in a rat model?
N-acetylcysteine partially ameliorates cisplatin-induced cardiotoxicity and oxidative stress in a rat model, suggesting potential as an adjunctive cardioprotective agent.
Answers are grounded in this paper and cite their sources.
NAC may attenuate cisplatin cardiotoxicity in rats; leaves open translation to human cardioprotection.
OBJECTIVES: Recent studies reported that oxidative stress is an important mechanism that contributes to cisplatin induced cardiotoxicity. In the present study, the effects of N-acetylcysteine (NAC), which is an antioxidant, on cisplatin induced cardiotoxicity were investigated in a rat model. METHODS: Thirty two rats were separated into 4 equal groups: Control, NAC-250, CP (cisplatin), CP+NAC. Rats in the experimental groups were treated with a single dose of cisplatin intraperitoneally (ip) (10 mg/kg) and NAC (ip, 250 mg/kg) for 3 consecutive days. At the end of the experiment, cardiotoxicity was determined from plasma CK-MB, LDH, cTnI and cardiac myosin light chain-1 (CMLC-1) levels. In the tissue samples, total oxidant capacity (TOC), total antioxidant capacity (TAC), lipid hydroperoxide (ROOH) and thiol levels were measured. The hearts were also analyzed histopathologically. RESULTS: It was determined that cisplatin increased the tissue TOC, ROOH levels and decreased TAC and thiol levels. NAC administration after cisplatin treatment was observed to have ameliorated histological and functional changes in heart. CONCLUSIONS: In conclusion, the results of this experimental study suggested that oxidative stress had a serious effect on cisplatin cardiotoxicity, and NAC could be used as a therapeutic agent in addition to standard cisplatin treatment protocols (Tab. 3, Fig. 1, Ref. 35).
No takes yet. Share an insight, caveat, or question.
Gunturk et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: